1. miR‐20a‐5p promotes pulmonary artery smooth muscle cell proliferation and migration by targeting ABCA1
   Yun Zhou et al, 2020, Journal of Biochemical and Molecular Toxicology CrossRef
2. Mechanisms of antidiabetic drugs and cholesterol efflux: A clinical perspective
   Ali Ahmadi et al, 2022, Drug Discovery Today CrossRef
3. Glucagon-Like Peptide 1 and Atrial Natriuretic Peptide in a Female Mouse Model of Obstructive Pulmonary Disease
   Emilie Balk-Møller et al, 2020, Journal of the Endocrine Society CrossRef
4. The anti-inflammatory feature of glucagon-like peptide-1 and its based diabetes drugs—Therapeutic potential exploration in lung injury
   Juan Pang et al, 2022, Acta Pharmaceutica Sinica B CrossRef
5. Association between glycated haemoglobin and the risk of chronic obstructive pulmonary disease: A prospective cohort study in UK biobank
   Mengyao Li et al, 2023, Diabetes, Obesity and Metabolism CrossRef
6. ABCA1 inhibits PDGF‐induced proliferation and migration of rat airway smooth muscle cell through blocking TLR2/NF‐κB/NFATc1 signaling
   Wei Cheng et al, 2018, Journal of Cellular Biochemistry CrossRef
7. Glucagon-like peptide-1 contributes to increases ABCA1 expression by downregulating miR-758 to regulate cholesterol homeostasis
   Yue Yao et al, 2018, Biochemical and Biophysical Research Communications CrossRef
8. Suppression of Glucagon-Like Peptide-1 Release by Inhibition of Intestinal NLRP3 Inflammasome Activation in Asc–/– and Nlrp3–/– Mice
   Yu Chen et al, 2019, Frontiers in Physiology CrossRef
9. Stabilizing Cellular Barriers: Raising the Shields Against COVID-19
   Julia Hanchard et al, 2020, Frontiers in Endocrinology CrossRef
10. Contribution of dipeptidyl peptidase 4 to non-typeable Haemophilus influenzae-induced lung inflammation in COPD
    Sudhir Kotnala et al, 2021, Clinical Science CrossRef
11. Potential therapeutic effect of glucagon-like peptide-1 receptor agonists on COVID-19-induced pulmonary arterial hypertension
    Jong Han Lee, 2022, Medical Hypotheses CrossRef
12. Potential Benefits and Harms of Novel Antidiabetic Drugs During COVID-19 Crisis
    Maria Mirabelli et al, 2020, International Journal of Environmental Research and Public Health CrossRef
13. Geniposide alleviates cholesterol-induced endoplasmic reticulum stress and apoptosis in osteoblasts by mediating the GLP-1R/ABCA1 pathway
    Mingliang Zhong et al, 2024, Journal of Orthopaedic Surgery and Research CrossRef
14. Endothelial Progenitor Cells as Pathogenetic and Diagnostic Factors, and Potential Targets for GLP-1 in Combination with Metabolic Syndrome and Chronic Obstructive Pulmonary Disease
    Evgenii Skurikhin et al, 2019, International Journal of Molecular Sciences CrossRef
15. Glucagon-like peptide-1 stimulates acute secretion of pro-atrial natriuretic peptide from the isolated, perfused pig lung exposed to warm ischemia
    Emilie Balk-Møller et al, 2022, Frontiers in Transplantation CrossRef
16. The role of GLP-1 receptor agonists during COVID-19 pandemia: a hypothetical molecular mechanism
    Yajnavalka Banerjee et al, 2021, Expert Opinion on Drug Safety CrossRef
17. Diabetic endothelial microangiopathy and pulmonary dysfunction
    Lanlan Zhang et al, 2023, Frontiers in Endocrinology CrossRef